Free tool
FAERS Monitor: Xyrem
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021196 or its brand name (Xyrem, Sodium Oxybate). Reports on generic versions are filed under their own applications.
Reports
62,191
Serious
32,274
52% of reports
Hospitalization
7,512
Death reported
941
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea4,303
- anxiety3,664
- somnolence3,187
- depression3,032
- headache2,931
- feeling abnormal2,899
- condition aggravated2,798
- weight decreased2,785
- fatigue2,672
- dizziness2,640
- insomnia2,567
- sleep apnoea syndrome2,550
- fall2,466
- pre-existing condition improved2,218
- drug ineffective2,181
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 45 |
| 2005 | 30 |
| 2006 | 53 |
| 2007 | 102 |
| 2008 | 138 |
| 2009 | 217 |
| 2010 | 328 |
| 2011 | 533 |
| 2012 | 909 |
| 2013 | 921 |
| 2014 | 1,831 |
| 2015 | 11,443 |
| 2016 | 19,535 |
| 2017 | 5,544 |
| 2018 | 4,530 |
| 2019 | 3,963 |
| 2020 | 3,142 |
| 2021 | 2,958 |
| 2022 | 2,041 |
| 2023 | 1,876 |
| 2024 | 1,124 |
| 2025 | 508 |
| 2026 | 420 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,968 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pre-existing condition improvedSignal | 2,218 | 185.7 | 176.5 | 262,833 |
| sleep apnoea syndromeSignal | 2,550 | 52.0 | 49.9 | 110,575 |
| somnolenceSignal | 3,187 | 5.4 | 5.2 | 11,419 |
| depressionSignal | 3,032 | 4.6 | 4.4 | 8,385 |
| anxietySignal | 3,664 | 4.4 | 4.3 | 9,622 |
| feeling abnormalSignal | 2,899 | 4.1 | 4.0 | 6,866 |
| weight decreasedSignal | 2,785 | 3.4 | 3.3 | 4,726 |
| insomniaSignal | 2,567 | 3.3 | 3.2 | 4,082 |
| condition aggravatedSignal | 2,798 | 3.1 | 3.0 | 4,080 |
| fallSignal | 2,466 | 2.5 | 2.4 | 2,273 |
| nausea | 4,303 | 1.8 | 1.8 | 1,715 |
| dizziness | 2,640 | 1.8 | 1.7 | 945 |
| headache | 2,931 | 1.6 | 1.5 | 646 |
| fatigue | 2,672 | 1.2 | 1.1 | 62 |
| drug ineffective | 2,181 | 0.6 | 0.5 | 808 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.